The problem at the heart of drug discovery: Lexogen & Ochre Bio on the power of AI on human data
Dylan Kissane
Our two guests this week: Quin Wills, CEO of Ochre Bio, and Stéphane Barges, CEO of Lexogen. The post The problem at the heart of drug discovery: Lexogen & Ochre Bio on the power of AI on human data appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to La